ASP
69 articles
Living Longer with Pancreatic Neuroendocrine Tumors
Dr. Pamela Hodul walks us through different types of pancreatic neuroendocrine tumors (PNET) and how rare they are along with the latest treatment options.
Handling the Changes Cancer Brings to Your Lifestyle
Drs. Sunil Hingorani and David Zhen discuss ways to handle lifestyle changes including work and diet during pancreatic cancer treatment.
Prognosis: More Than Numbers in Pancreatic Cancer
What is pancreatic cancer prognosis? Dr. Joshua Lakin of Harvard explains how prognosis works, and ways to possibly defy the odds when facing a slow recovery.
Meet the World Pancreatic Cancer Coalition
The World Pancreatic Cancer Coalition shows there is power when advocacy groups join together for the cause: World Pancreatic Cancer Day.
Steven Merlin and Davi D’Agostino Team Up to Help Others
Pancreatic cancer patient advocates Steven Merlin and Davi D’Agostino have joined to pool expertise and information for other patients.
Pancreatic Cancer Can Mimic Other Health Problems
Cindy Lopez thought she had back problems, but she was diagnosed with pancreatic cancer. Chemotherapy and radiation shrunk the tumor for surgery.
Comparing the Effectiveness of Vaccine Therapy With or Without Additional Immunotherapy
Can the immunotherapy combination of cancer vaccines and a checkpoint blockade drug work against metastatic pancreatic cancer?
Listen to Your Body
When Roxanne Waling discovered she had pancreatic cancer she underwent genetic testing. She found she was a BRCA2 carrier, which influenced her post-treatment decisions about her health.
Embracing Optimism
Laurie MacCaskill is a long-term survivor of pancreatic cancer. She followed a personalized treatment plan, and focused her energy on remaining optimistic.
Low-Dose Continuous Chemotherapy as Part of a New Combination of Drugs
A clinical trial uses a new immunotherapy drug in combination with standard chemotherapy drugs in metronomic therapy to treat metastatic pancreatic cancer.
Exploring the Better Treatment for Stable Metastatic Pancreatic Cancer
For patients with stable metastatic pancreatic cancer, a clinical trial compares standard chemotherapy with immunotherapy.
Genetic Testing Leads Me to a PARP Inhibitor Trial
Harvey Parker had genetic testing as part of his initial pancreatic cancer treatment. The BRCA2 mutation led him to a PARP inhibitor clinical trial.
Finding a Clinical Trial
Let’s Win’s Trial Finder Clinical trials are important to consider for pancreatic cancer patients at all stages of the disease. Trials provide access to cutting-edge treatments not yet widely available, offering hope and potentially better outcomes. Studies are taking place at numerous locations across the United States, making participation more accessible than ever. Let’s Win […]
Newly Diagnosed
What to Do If You Have Recently Been Diagnosed with Pancreatic Cancer You or someone you love has been diagnosed with pancreatic cancer. Now what? First, know that you are not alone in this overwhelming moment. No one should have to face pancreatic cancer without trusted resources and hope. Let’s Win is a go-to guide […]
Kerri Kaplan
Kerri Kaplan is the President of the Lustgarten Foundation, which is America’s largest private funder of pancreatic cancer research and is relentlessly focused on improving patient outcomes. Kerri oversees all aspects of the Lustgarten Foundation’s operational activities, including major fundraising initiatives, patient outreach, and the Foundation’s in-depth research portfolio. Early in her career at the […]